Haemonetics Announces 1,623-Patient Study Of VASCADE MVP XL Closure System Showing 92.5% Same-Day Discharge Rate And 1.2% Overall Vascular Complications
Share
Why It Matters
Haemonetics tested a medical device that helps doctors close blood vessel holes after procedures, and it worked really well—most patients went home the same day with very few problems. When a company shows their product works safely and well, people pay attention to see if it might make them money in the future.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.